Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015

1
Chronic Kidney Disease (Chronic Renal Failure)
Global Clinical Trials Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Chronic Kidney Disease (Chronic Renal Failure)
  Global Clinical Trials Review, H2, 2015" provides
  an overview of Chronic Kidney Disease (Chronic
  Renal Failure) clinical trials scenario. This
  report provides top line data relating to the
  clinical trials on Chronic Kidney Disease
  (Chronic Renal Failure). Report includes an
  overview of trial numbers and their average
  enrollment in top countries conducted across the
  globe. The report offers coverage of disease
  clinical trials by region, country (G7 E7),
  phase, trial status, end points status and
  sponsor type. Report also provides prominent
  drugs for in-progress trials (based on number of
  ongoing trials).
• Scope
• - The report provides a snapshot of the global
  clinical trials landscape
• - Report provides top level data related to the
  clinical trials by Region, Country (G7 E7),
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• - The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• - The report provides all the unaccomplished
  trials (Terminated, Suspended and Withdrawn) with
  reason for unaccomplishment
• - The Report provides enrollment trends for the
  past five years
• - Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/chroni
  c-kidney-disease-chronic-renal-failure-global-clin
  ical-trials-review-h2-2015-market

3


Table of Content
Table of Contents 2List of Tables 3List of
Figures 4Report Guidance 5Clinical Trials by
Region 6Clinical Trials and Average Enrollment
by Country 7Top Five Countries Contributing to
Clinical Trials in Asia-Pacific 10Top Five
Countries Contributing to Clinical Trials in
Europe 11Top Countries Contributing to Clinical
Trials in North America 12Top Five Countries
Contributing to Clinical Trials in Middle East
and Africa 13Top Five Countries Contributing to
Clinical Trials in Central and South America
14Clinical Trials by G7 Countries Proportion of
Chronic Kidney Disease (Chronic Renal Failure) to
Genito Urinary System And Sex Hormones Clinical
Trials 15Clinical Trials by Phase in G7
Countries 17Clinical Trials in G7 Countries by
Trial Status 18Clinical Trials by E7 Countries
Proportion of Chronic Kidney Disease (Chronic
Renal Failure) to Genito Urinary System And Sex
Hormones Clinical Trials 19Clinical Trials by
Phase in E7 Countries 21Clinical Trials in E7
Countries by Trial Status 22Clinical Trials by
Phase 23In Progress Trials by Phase 24Clinical
Trials by Trial Status 25
4


Table of Content
Clinical Trials by End Point Status 26Subjects
Recruited Over a Period of Time 27Clinical
Trials by Sponsor Type 28Prominent Sponsors
29Top Companies Participating in Chronic Kidney
Disease (Chronic Renal Failure) Therapeutics
Clinical Trials 31Prominent Drugs 33Latest
Clinical Trials News on Chronic Kidney Disease
(Chronic Renal Failure) 34Oct 06, 2015 Akebia
Reaches Agreement with FDA and EMA on Vadadustat
Global Phase 3 Program 34Oct 05, 2015 Results
from Mercks Phase 3 Study of Investigational
Chronic Hepatitis C Therapy Elbasvir/Grazoprevir
in Patients with Advanced Chronic Kidney Disease
Published in The Lancet 34Oct 05, 2015 Atara
Bios Collaborating Investigators to Present Data
at the American Society of Nephrology Kidney Week
2015 35Sep 08, 2015 Akebia Announces Positive
Top-Line Results from its Phase 2 Study of
Vadadustat in Dialysis Patients with Anemia
Related to Chronic Kidney Disease 35Aug 04,
2015 International Clinical Steering Committee
Announced for Resverlogixs Phase 3 BETonMACE
Clinical Trial with RVX-208 "apabetalone"
36Clinical Trial Profile Snapshots 38Appendix
1020 Enquire At http//www.researchbeam.com/chr
onic-kidney-disease-chronic-renal-failure-global-c
linical-trials-review-h2-2015-market/enquire-about
-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/chronic-kidney-disease
-chronic-renal-failure-global-clinical-trials-revi
ew-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com